Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice

Drugs under Experimental and Clinical Research

Volumn 22, Issue 2, 1996, Pages 35-40

  Umezawa, K ^a   Taniguchi, T ^b   Toi, M ^b   Ohse, T ^a   Tsutsumi, N ^a   Yamamoto, T ^c   Koyano, T ^c   Ishizuka, M ^d  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c TERUMO CORPORATION   (Japan)

^d Numazu Bio Medical Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONOPHYLLINE; DEOXYGLUCOSE; PLANT EXTRACT; UNCLASSIFIED DRUG; VINCA ALKALOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL CULTURE; CELL STRUCTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKEMIA; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE K RAS; PHENOTYPE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATTLE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENES, RAS; MICE; MICE, NUDE; TUMOR CELLS, CULTURED; VINCA ALKALOIDS;

EID: 0029790654     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Bos J.L. Ras oncogene in human cancer: a review. Cancer Res., 49, 4682, 1989.
2. Itoh O., Kuroiwa S., Atsumi S., Umezawa K., Takeuchi T., Hori M. Induction of the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells. Cancer Res., 49, 996, 1989.
3. Matsuda N., Kageyama S., Endo A., Umezawa K. Induction of normal phenotypes and potentiation of 5-fluorouracil by an HMG-CoA reductase inhibitor, compactin, in ras-transformed cells. Cellular Pharmacol., 1, 219, 1994.
4. Umezawa K., Ohse T., Yamamoto T., Koyano T., Takahashi Y. Isolation of a new vinca alkaloid from the leaves of Ervatamia microphylla as an inhibitor of ras functions. Anticancer Res., 14, 2413, 1994.
5. Karn T.S., Loh K.Y., Wei C. Conophylline and conophyllidine: new dimeric alkaloids from Tabernaemontana divaricata. J. Nat. Prod., 56, 1865, 1993.
6. Kozma L, Baltensperger K., Klarlund J., Porras A., Santos E., Czech M.P. The ras signaling pathway mimics insulin action on glucose transporter translocation. Proc. Natl. Acad. Sci. USA, 90, 4460, 1993.
7. Flier J.S., Mueckler M.M., Usher R., Lodish H.F. Elevated levels of glucose transporter messenger RNA are induced by ras or src oncogene. Science, 235, 1492, 1987.
8. Kim J.H., Stambuk B.K. Synchronization of HeLa cells by vinblastine sulfate. Exp. Cell Res., 44, 631, 1966.
9. Jakobisiak M., Brano S., Skirski I.S., Darzynkiewiaz Z. Cell cycle-specific effect of lovastatin. Proc. Natl. Acad. Sci. USA, 88, 3628, 1991